�_�l(f��)�M�㲻ͬ�ض������Ĺ��ܲ����������t(y��)�W(xu��)�Б�(y��ng)�þ�������������(zh��n)�ԡ���֦��ۺ������{���侫�_�ĽY(ji��)��(g��u)�Ͷ��r(ji��)�f(xi��)ͬ�ԣ������ƾ��ܹ��ܲ��ϵ䷶���������������ҿƌW(xu��)�о�����-�Rِ��W(xu��)�Ƽ{���о������c�Ї�ˎ�ƴ�W(xu��)�������ɹ��_�l(f��)��һ�N����bola�̓��H�Ԙ��η�����bola-amphiphilic dendrimers�������_�d�wƽ�_(t��i), ���x�����f�Ͳ�ͬ��ͺ���ˎ����siRNA��DNA��(Figure 1)�������[���ί����Y(ji��)���l(f��)�����C�����ڿ�Proceedings of the National Academy of Sciences of the U. S. A.(DOI: 10.1073/pnas.2220787120)
�����F(tu��n)�(du��)�O(sh��)Ӌ(j��)���_�l(f��)�˲�ͬ����(sh��)��bola�̓��H�Ԙ��η�������(du��)���f�Ͳ�ͬ������ӵ������M(j��n)�����о����Y(ji��)��������bola���η��ӵĴ���(sh��)����������Ĵ�С�Լ�bola���η����c��������֮�g���r(ji��)�f(xi��)ͬ�����ںܴ�̶���Ӱ����x�����f�ͺ������ӵ���������������������(sh��)��bola8A������Ч������ߴ��|(zh��)��DNA ���s��С�ļ{��(f��)����@�������DNA���м�(x��)���Ĕzȡ��չ�F(xi��n)��������(y��u)����DNA�D(zhu��n)Ⱦ�������^�ʹ���(sh��)��bola4A�t����Ч���o(h��)���siRNA���ӵ�ͬ�r(sh��)��������Ч�ش��M(j��n)siRNA �İ���(n��i)ጷţ��M(j��n)���l(f��)�]��(qi��ng)�����Ļ����ĬЧ�� (Figure 2)������, ԓ�bola���H�Ԙ��η�������(g��u)��������ˎ���f��ϵ�y(t��ng)���x�����������[���M���������[����(x��)����(n��i)ROS�̼����خ�����ጷ���������(sh��)�F(xi��n)����ˎ�����[����(x��)���İ����f������������ϲ���ǣ������f���wϵ���m�i�����ѳ������N��ֲС���[��ģ�����Լ������u�Եĺ�ɫ��������������ٰ��D(zhu��n)��ģ�����������F(xi��n)���������̘I(y��)���d�w�������f��Ч�����܉�����(zh��n)�{(di��o)���²������ı��_(d��)���l(f��)�]��Ч�Ŀ��[�����������[���D(zhu��n)��Ч�� (Figure 3)�����о��ɹ����@��bola�̓��H�Ԙ��η������鰴�����ƺ���ˎ���f���d�w�ľ�����
Fig. 3. Effective inhibition of tumor metastasis using DNA and siRNA therapeutics delivered by bola8A and bola4A respectively in lung metastatic cancer model. (A-E) 4T1-luc metastatic tumor-bearing mice received intravenous injections of PBS buffer (control), p53 alone, p53/bola8A complex, p53/Lipo complex (2.0 mg/kg DNA, 1.5 mg/kg bola8A, N/P ratio of 1.0), siAKT2 alone, siAKT2/bola4A complex, or siAKT2/MC3 complex (1.0 mg/kg siRNA, 3.9 mg/kg bola4A, N/P ratio of 5.0) (n=5): (A) In vivo bioluminescence imaging of 4T1-luc tumor metastases in the mice. (B) Ex vivo bioluminescence imaging of 4T1-luc tumor metastases in the lung at the experimental end point post treatment. (C) Histological analysis of lung tissues from 4T1-luc metastatic tumor-bearing mice at the experimental end point post treatment. The metastatic lesions (red solid outlines) were identified as cell clusters with darkly stained nuclei. Scale bars, 1 mm. (D) p53 and (E) AKT2 protein expression revealed by immunohistochemistry staining after treatments. Scale bar, 200 ��m. (F-J) B16-F10-luc metastatic tumor-bearing mice received intravenous injections of PBS buffer (control), p53 alone, p53/bola8A complex, p53/JetPEI complex (2.0 mg/kg DNA, 1.5 mg/kg bola8A, N/P ratio of 1.0), siAKT2 alone, siAKT2/bola4A complex, or siAKT2/MC3 complex (1.0 mg/kg siRNA, 3.9 mg/kg bola4A, N/P ratio of 5.0) (n=5): (F) in vivo bioluminescence imaging of B16-F10-luc tumor metastases in the mice. (G) Ex vivo bioluminescence imaging of B16-F10-luc tumor metastases in the lung tissue or images of excised lung tissues at the experimental end point post treatment. (H) Histological analysis of lung tissues from B16-F10-luc metastatic tumor-bearing mice at the experimental end point post treatment. The metastatic lesions (red solid outline) were identified as cell clusters with darkly stained nuclei. Scale bars, 1.0 mm. (I) p53 and (J) AKT2 protein expression revealed by immunohistochemistry staining after treatments. Scale bar, 200 ��m. p53: plasmid DNA expressing tumor suppressor protein p53, siAKT2: siRNA targeting AKT2.
ԭ��朽���https://www.pnas.org/doi/10.1073/pnas.2220787120
- ��������˹-�Rِ��W(xu��)����/�Ї�ˎ�t�/�۴��S˼�R ACS AMI�����H�Ԙ��η��Ӱ��������R����ᘌ�(du��)�D(zhu��n)�����ѳ�������Ч�ί����� 2025-01-06
- ���u��W(xu��)�ڝ��������шF(tu��n)�(du��)��ACS AMI�������A��푑�(y��ng)�ͼ{��(f��)����ͨ�^���ƿڷ�����ˎ���ڽY(ji��)�c��(n��i)����e�ͷֲ���p�p�����ԽY(ji��)�c�� 2022-04-08
- ����W(xu��)�����½����n�}�M��Nat. Commun.�����ۺ���{�����DNA�r(sh��)�վ��̼�(j��)(li��n)�M�b�x�ܺ���ˎ�ᆱ��(zh��n)�f�� 2021-02-19
- ������/���f/�Y�� JACS���l(f��)չ�ۺ���C֬�|(zh��)�d�wͨ�^�䷽��(y��u)������mRNA�����x�����f�͵Ķ����A(y��)�yģ�� 2026-03-03
- ����������W(xu��)���d���ڈF(tu��n)�(du��)��Adv.Healthc.Mater.���������p�����ص�pH푑�(y��ng)�͟o�d�w�{��ˎ���Ч�ί���ϼ�(x��)����Ⱦ 2025-08-11
- �Ї��r(n��ng)��Ժֲ�����������о��T Small����(y��u)���Ŀɇ�ʩ���w�S�d�w���ڸ�Ч�r(n��ng)ˎ�f�� 2025-06-13
- �㽭��W(xu��)��������������ܽ��ڈF(tu��n)�(du��) JCIS�����ڰ�ȫ�Ź������ʹ̼�푑�(y��ng)ˎ���f�͵ļ{������ 2025-09-09
�\���P(gu��n)ע�߷��ӿƼ�
- 2026����ߌ��Ї���(sh��)�(y��n)�Ұl(f��)չ...
- �����I(l��ng)Ʊح300+���h��I(y��)�R��...
- �P(y��ng)���Ж|�����L���Ѓx�����{(l��n)...
- �f����Ŀ �ذ��_����2025�C(j��)...
- ICIE���H(�V��)Ϳ�Ϲ��I(y��)չ�[...
- �_չ�ڼ����ۄ�������朄�(d��ng)δ...
- 9������Ҋ���£�AI�(q��)��(d��ng)+���a(ch��n)...
- �P(gu��n)���e�k�ڶ�ʮ�����Ї����H...
- �R�ۼ�˃x�� ����ȫ���̙C(j��) ...
- CPHI����չ��(sh��)�(y��n)�҃x���c�O(sh��)��...
- ���ܹ��A��朆���������22��...
- ������/���f/�Y�� JACS���l(f��)...
- ��ɽ��W(xu��)��־�x�����w�����...
- ���������������ֈF(tu��n)�(du��) Angew...
- �Ϻ�����/��������(sh��)�(y��n)��...
- ���t(y��)��һ��Ժʢ�������/�A...
- �пƴ���Ƙ�������������/...
- �����������/������������...
- �㹤��������/�~��(hu��)Ҋ�n�}�M ...
- ��������-��־�F(tu��n)�(du��) AFM �C��...
- �|�ϴ�W(xu��)��������ڈF(tu��n)�(du��) Nat...
- ���ݴ�W(xu��)Ҧ����/κ��/����Ӱ...